MONMOUTH JUNCTION, NJ , May 10, 2018 -- Biotech Support Group will exhibit at the annual American Society for Mass Spectrometry (ASMS) Conference, June 3-7, 2018 in San Diego, CA. The conference highlights the most recent advancements in Mass Spectrometry technology applications and expects an attendance of 6,500 scientists and 3,000 presentations as talks and posters.

Featured at our Booth 405, will be consumable sample prep products for proteome enrichment, and on-bead digestion for rapid and streamlined workflows to improve quantification of label and label-free proteomics. In addition, there will be two technical poster reports describing the advantageous use of our products for serum applications:

The first is entitled “Profiling low abundant species in sera with coupled use of an innovative Albumin depletion sample preparation and MALDI-MS”, co-authored with collaborators from Ascend Diagnostics.

The second is entitled “Stroma Liquid Biopsy – Pan-Cancer Dysregulation of the Serum Proteome”, co-authored with collaborators from the Rutgers Proteomics Center.

Both posters will be presented on Monday June 4. For more information about our Sample Prep Mass Spectrometry Products click here!

“We will be highlighting our many successes over the past 6 months at this Conference. This includes our patent application on our cancer biomarker panel, our most recent data on our consumable proteomic sample prep product AlbuVoid™ On-Bead LC-MS, and coupled use of our sample prep to a new downstream versatile platform – MALDI-MS. It is very exciting to share these developments with an industry group at the forefront of life science research”, states Dr. Swapan Roy, Ph.D., President and Founder of Biotech Support Group.

About Biotech Support Group LLC

Converging with cultural and technological disruptions forthcoming in healthcare, Biotech Support Group develops methods for cost effective and efficient sample prep essential for these expanding markets. Following a tiered business strategy, the company continues its growth in the consumable research products area supporting the rapidly expanding installation of LC-MS instrument and computational infrastructure. For this market, key products include: AlbuVoid™ and AlbuSorb™ for albumin depletion, Cleanascite™ for lipid adsorption, HemogloBind™ and HemoVoid™ for hemoglobin removal, and NuGel™ for functional proteomics. From these innovations, the company has acquired knowledgebase and biomarker intellectual property assets that support discoveries of protein markers from blood, with special emphasis on early detection and personalized medical decisions for cancer patients. For more information, go to http://www.biotechsupportgroup.com

Contact:

Matthew Kuruc 732-274-2866
mkuruc@biotechsupportgroup.com